MedPath
TGA Approval

SETRELVO ustekinumab 90 mg/ 1 mL solution for injection pre-filled pen (One-Press patient-controlled injector) (462464)

462464

SETRELVO ustekinumab 90 mg/ 1 mL solution for injection pre-filled pen (One-Press patient-controlled injector)

Janssen-Cilag Pty Ltd

October 18, 2024

Medicine

Medicine

Active

Registered

Active Ingredients

Ustekinumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.